Skip to main content
Caplight Logo









AvoMD

AvoMD

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.avomd.com/

Last Round

Series A

Mar 31, 2026

Total Funding Raised

$18M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

AvoMD is a healthcare technology company that provides a no-code platform for clinicians and hospitals to build and deploy point-of-care decision support applications.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, Medical AI, Workflow Automation, NLP & Conversational AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical decision supportautomated clinical documentationambient documentationAI scribeEHR integrationelectronic health recordEHRclinical workflow automationmedical AIclinical documentation improvementchart summarizationhealthcare SaaSAI health assistantclinical pathway automationphysician burnout solutions

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AvoMD Comparables

Compare AvoMD with similar companies based on industry and business-model similarity.

AvoMD comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Glass Health
85%
EvidenceCare
83%
DeepScribe
82%

AvoMD Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 31, 2026
SeedJun 23, 2023
SeedJul 9, 2021

Key People

Founding team and executive leadership

Joongheum Park

Cofounder Chairman And CPO

Founding Team

Laurence Coman

COO and Cofounder

Founding Team

AvoMD Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2026

    Grew 27% QoQ from 44 to 56 employees.

  • Jul 31, 2026

    Grew 26% QoQ, from 42 to 53 employees.

Recent news

Latest coverage and updates

  • partners_withSep 17, 2026

    AvoMD, Inc. partners with NeighborHealth.

  • partners_withSep 17, 2026

    AvoMD, Inc. partners with Marathon Health, LLC.

  • partners_withSep 17, 2026

    AvoMD, Inc. partners with Emanate Health.

AvoMD Filings

Explore SEC and related filing metadata, where available.

AvoMD filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AvoMD's valuation, stock price, and market status.

Is AvoMD a public or private company?

AvoMD is a private company.

What is the current stock price of AvoMD?

AvoMD is a private company with no public stock price. No recent secondary market data is available.

How much is AvoMD worth (valuation)?

Valuation information for AvoMD is not publicly available.

Can I buy AvoMD stock?

AvoMD shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AvoMD's last funding round?

AvoMD's most recent funding round was Series A on March 31, 2026.

Who are the main investors in AvoMD?

Key investors in AvoMD include AlleyCorp, Noro-Moseley Partners.

Will AvoMD IPO soon?

No public IPO plans have been announced for AvoMD.

How can I track AvoMD secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AvoMD's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range43
Year Founded2018
Last FundingMar 31, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?